(Q39443380)

12 September 2017

Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound (English)

1 reference

12 September 2017

7

1 reference

12 September 2017

9

Lieber MM

1 reference

12 September 2017

2

Girman CJ

1 reference

12 September 2017

Roehrborn CG

1

1 reference

12 September 2017

Rhodes T

3

1 reference

12 September 2017

Hanson KA

4

1 reference

12 September 2017

Collins GN

5

1 reference

12 September 2017

Sech SM

6

1 reference

12 September 2017

Garraway WM

8

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

12 September 2017

1 reference

12 September 2017

49

1 reference

12 September 2017

4

1 reference

12 September 2017

548-557

1 reference

Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

This month in investigative urology: alpha adrenergic innervation of the prostate: insights into pharmacotherapy of BPH

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

The efficacy and safety of terazosin for the treatment of symptomatic BPH

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

Are Doctors Able to Assess Prostatic Size?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

Accuracy in preoperative estimation of prostatic size. A comparative evaluation of rectal palpation, intravenous pyelography, urethral closure pressure profile recording and cystourethroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

The prevalence of prostatism: a population-based survey of urinary symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

High prevalence of benign prostatic hypertrophy in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

Ultrasonically determined patterns of enlargement in benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

Determination of prostate volume by transrectal ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

Inter-observer variation in assessment of the prostate by digital rectal examination

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

Accuracy of preoperative estimation of resection weight in transurethral prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

The role of transabdominal ultrasound in the preoperative evaluation of patients with benign prostatic hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

Measurements of size and weight of prostate by means of transrectal ultrasonotomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

Determination of prostate volume with transrectal US for cancer screening. Part II. Accuracy of in vitro and in vivo techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

Reproducibility and observer variability of transrectal ultrasound measurements of prostatic volume

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

Using repeated measures of symptom score, uroflowmetry and prostate specific antigen in the clinical management of prostate disease. Benign Prostatic Hyperplasia Treatment Outcomes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900031-9

7 January 2021

10.1016/S0090-4295(97)00031-9

Identifiers

DOI

1 reference

12 September 2017

1 reference